Bradley, M. ., Markesbery, W. ., & Lovell, M. . (2010). Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radical Biology & Medicine, 48(12), 1570-6. https://doi.org/10.1016/j.freeradbiomed.2010.02.016 (Original work published 2010)

Bradley, M. ., Xiong-Fister, S. ., Markesbery, W. ., & Lovell, M. . (2012). Elevated 4-hydroxyhexenal in Alzheimer’s disease (AD) progression. Neurobiology of Aging, 33(6), 1034-44. https://doi.org/10.1016/j.neurobiolaging.2010.08.016

Lovell, M. ., Xiong, S. ., Markesbery, W. ., & Lynn, B. . (2005). Quantitative proteomic analysis of mitochondria from primary neuron cultures treated with amyloid beta peptide. Neurochemical Research, 30(1), 113-22. https://doi.org/10.1007/s11064-004-9692-5

Lovell, M. ., Geiger, H. ., Van Zant, G. ., Lynn, B. ., & Markesbery, W. . (2006). Isolation of neural precursor cells from Alzheimer’s disease and aged control postmortem brain. Neurobiology of Aging, 27(7), 909-17. https://doi.org/10.1016/j.neurobiolaging.2005.05.004

Williams, T. ., Lynn, B. ., Markesbery, W. ., & Lovell, M. . (2006). Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer’s disease. Neurobiology of Aging, 27(8), 1094-9. https://doi.org/10.1016/j.neurobiolaging.2005.06.004

Lovell, M. ., Lynn, B. ., Xiong, S. ., Quinn, J. ., Kaye, J. ., & Markesbery, W. . (2008). An aberrant protein complex in CSF as a biomarker of Alzheimer disease. Neurology, 70(23), 2212-8. https://doi.org/10.1212/01.wnl.0000312383.39973.88 (Original work published 2008)

Lynn, B. ., Wang, J. ., Markesbery, W. ., & Lovell, M. . Quantitative changes in the mitochondrial proteome from subjects with mild cognitive impairment, early stage, and late stage Alzheimer’s disease. Journal of Alzheimer’s Disease : JAD, 19(1), 325-39. https://doi.org/10.3233/JAD-2010-1254 (Original work published 2010)

Hensley, K. ., Butterfield, D. ., Hall, N. ., Cole, P. ., Subramaniam, R. ., Mark, R. ., … Aksenov, M. . (1996). Reactive oxygen species as causal agents in the neurotoxicity of the Alzheimer’s disease-associated amyloid beta peptide. Annals of the New York Academy of Sciences, 786, 120-34. https://doi.org/10.1111/j.1749-6632.1996.tb39057.x (Original work published 1996)

Aksenov, M. ., Aksenova, M. ., Markesbery, W. ., & Butterfield, D. . (1998). Amyloid beta-peptide (1-40)-mediated oxidative stress in cultured hippocampal neurons. Protein carbonyl formation, CK BB expression, and the level of Cu, Zn, and Mn SOD mRNA. Journal of Molecular Neuroscience : MN, 10(3), 181-92. https://doi.org/10.1007/BF02761773

Aksenova, M. ., Aksenov, M. ., Payne, R. ., Trojanowski, J. ., Schmidt, M. ., Carney, J. ., … Markesbery, W. . (1969). Oxidation of cytosolic proteins and expression of creatine kinase BB in frontal lobe in different neurodegenerative disorders. Dementia and Geriatric Cognitive Disorders, 10(2), 158-65. https://doi.org/10.1159/000017098 (Original work published 1969)